MBX Biosciences posts updated corporate presentation; no material financial or pipeline updates disclosed

MBX Biosciences, Inc.

Company posted updated corporate presentation on its website on June 9, 2025.
Presentation is dated June 2025 and features the 'Precision Endocrine Peptides' tagline.
No specific data on clinical programs, financials, or guidance changes were provided in the filing.
Exhibit 99.1 (presentation) was only partially reproduced; full content not available for analysis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.